NeurAxis, Inc. (NRXS)
6.21
+0.10
(+1.64%)
USD |
NYAM |
Nov 06, 10:20
NeurAxis Total Liabilities (Quarterly) : 3.261M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.261M |
| March 31, 2026 | 2.998M |
| December 31, 2025 | 3.005M |
| September 30, 2025 | 3.491M |
| June 30, 2025 | 2.835M |
| March 31, 2025 | 2.771M |
| December 31, 2024 | 2.690M |
| September 30, 2024 | 2.937M |
| June 30, 2024 | 7.892M |
| March 31, 2024 | 4.130M |
| Date | Value |
|---|---|
| December 31, 2023 | 1.913M |
| September 30, 2023 | 2.297M |
| June 30, 2023 | 11.52M |
| March 31, 2023 | 9.325M |
| December 31, 2022 | 7.054M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 1.586M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 56.62B |
| AngioDynamics, Inc. | 77.97M |
| Alphatec Holdings, Inc. | 775.44M |
| AtriCure, Inc. | 184.31M |
| Baxter International, Inc. | 12.94B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.996M |
| Shareholders Equity (Quarterly) | 6.735M |
| Debt to Equity Ratio | 0.0415 |
| Current Ratio | 3.040 |
| Net Debt Paydown Yield | 0.02% |